lncRNA NEAT1通过抑制hsa-miR-450b-5p促进胃癌细胞中EZH2的表达与细胞的增殖和迁移能力

被引:0
|
作者
贺娇
任伟宏
机构
[1] 河南中医药大学第一附属医院检验科
关键词
胃癌; lncRNA NEAT1; 果蝇Zeste基因增强子同源物2(EZH2); miRNA; 增殖; 迁移;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
摘要
目的:筛选果蝇Zeste基因增强子同源物2(EZH2)基因上游miRNA及lncRNA,分析其在胃癌细胞中的表达并验证其间的靶向关系,探讨它们对胃癌细胞增殖、迁移和凋亡的影响。方法:通过ENCORI、miRDB和Target Scan数据库查询并分析、筛选EZH2上游miRNA(has-miR-450b-5p),ENCORI数据库和DAINA数据库筛选has-miR-450b-5p上游lncRNA(lncRNA NEAT1),预测hsa-miR-450b-5p、lncRNA NEAT1与EZH2之间的结合位点,双荧光素酶报告基因实验验证hsa-miR-450b-5p与lncRNA NEAT1的结合关系。采用q PCR和WB法检测lncRNA NEAT1和EZH2在正常胃黏膜细胞(GES-1)与胃癌细胞(MGC-803、SGC-7901和MKN-28)中的表达量。按转染物的不同将MGC-803和SGC-7901细胞分为hsa-miR-450b-5p-mimic组、mimicNC组、si-NEAT1组和si-NC组,转染36~48 h后qPCR法验证过表达及敲减效果;通过qPCR、WB法检测观察过表达hsa-miR-450b-5p对细胞中lncRNANEAT1和EZH2m RNA、蛋白表达的影响,以及敲减lncRNANEAT1对hsa-miR-450b-5p和EZH2mRNA表达的影响;CCK-8法、划痕愈合实验和流式细胞术分别检测敲减EZH2或敲减lncRNA NEAT1对细胞增殖、迁移和凋亡能力的影响。结果:生物信息学分析筛选获得EZH2上游miRNA和lncRNA为has-miR-450b-5p和lncRNA NEAT1,双荧光素酶报告基因实验验证了两者间存在靶向关系。lncRNA NEAT1和EZH2 mRNA、蛋白在胃癌细胞中均呈高表达(均P<0.05)。与mimic-NC组相比,hsa-miR-450b-5p-mimic组MGC-803、SGC-7901细胞中miR-450b-5p水平均显著升高,而EZH2 mRNA、蛋白和lncRNA NEAT1的表达量均显著降低(P<0.05或P<0.01);与si-NC组相比,si-NEAT1组MGC-803、SGC-7901细胞中lncRNA NEAT1和EZH2 mRNA的表达量均显著降低(均P<0.01),SGC-7901细胞中hsa-miR-450b-5p表达量显著升高(P<0.05)。敲减EZH2或敲减lncRNA NEAT1后,MGC-803、SGC-7901细胞的增殖、迁移能力均显著降低(均P<0.01)。结论:lncRNA NEAT1和EZH2在胃癌细胞中均呈高表达,lncRNA NEAT1可通过hsa-miR-450b-5p促进EZH2的表达并提高胃癌MGC-803和SGC-7901细胞的增殖和迁移能力。
引用
收藏
页码:135 / 145
页数:11
相关论文
共 21 条
  • [1] miR-32-5p通过靶向下调EZH2的表达抑制胰腺癌PANC-1细胞的恶性生物学行为与裸鼠移植瘤生长
    柳君君
    张燕燕
    雷衡阳
    [J]. 中国肿瘤生物治疗杂志, 2022, 29 (06) : 557 - 566
  • [2] The roles of EZH2 in cancer and its inhibitors[J] Liu Yuankai;Yang Qiong Medical Oncology 2023,
  • [3] The role of EZH1 and EZH2 in development and cancer.[J] Lee Soo Hyun;Li Yingying;Kim Hanbyeol;Eum Seounghyun;Park Kyumin;Lee ChulHwan BMB reports 2022,
  • [4] BMP2 inhibits cell proliferation by downregulating EZH2 in gastric cancer.[J] Chen Zilu;Yuan Liyue;Li Xiaopeng;Yu Junhui;Xu Zhengshui Cell cycle (Georgetown; Tex.) 2022,
  • [5] EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation[J] Zhang Lin;Qu Jingkun;Qi Yutao;Duan Yimin;Huang Yu Wen;Zhou Zhifen;Li Ping;Yao Jun;Huang Beibei;Zhang Shuxing;Yu Dihua Nature Communications 2022,
  • [6] Identification of the upstream regulators of KDM5B in gastric cancer[J] Zhao Long Fei;Qi Feng Yu;Zhang Jin Ge;Pang Jing Ru;Ren Hong Mei;Shen Dan Dan;Zhao Li Juan;Qi Lin;Liu Hong Min;Zheng Yi Chao Life Sciences 2022,
  • [7] The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme[J] Wang Liang;Cao Haiyan;Zhong Ying;Ji Peigang;Chen Fan Frontiers in Cell and Developmental Biology 2022,
  • [8] Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network.[J] Hao Aixin;Wang Yunxuan;Stovall Daniel B;Wang Yu;Sui Guangchao International journal of biological sciences 2021,
  • [9] EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.[J] Wen Yiping;Hou Yaya;Yi Xiaoqing;Sun Si;Guo Jing;He Xiaoqi;Li Tao;Cai Jing;Wang Zehua Theranostics 2021,
  • [10] Gastric cancer[J] Elizabeth C Smyth;Magnus Nilsson;Heike I Grabsch;Nicole CT van Grieken;Florian Lordick The Lancet 2020,